• PRINT
  • Bookmark and Share

Research in Uganda

BIPAI Uganda performs clinical research under stringent standards and its findings contribute to worldwide best practices of pediatric HIV/AIDS care and treatment.

The ARROW Trial and the Cohort studies continue with the longest attending study participants at week 165 and 291 respectively.  The trial has undertaken new randomizations to stop or continue cotrimoxazole and once verses twice daily Abacavir + Lamivudine which when completed are hoped to further improve adherence of children to their life-long ART. The cohort study is now assembling an infant cohort starting HAART as per the current Uganda Ministry of Health and WHO guidelines.

The Adolescent intervention study has completed the first phase of developing the pilot intervention tailored to the needs of YPLH in Uganda and will proceed to evaluate the intervention among them.

Additional research recently completed at BIPAI Uganda includes:

  • Evaluation of the T-Spot TB test in the diagnosis of latent tuberculosis infection in HIV-infected children in Uganda
  • HIV-associated malignancies among children attending the BIPAI Uganda COE in Kampala, Uganda
  • Association between anthropometric status and dietary diversity of complementary feeding among infants born to HIV-infected mothers in Uganda
  • Formative evaluation of nutrition care and support interventions for children exposed to and infected with HIV and AIDS at BIPAI Uganda

In the coming year, BIPAI Uganda will begin a new trial, CHAPAS 3 (Children with HIV in Africa -Pharmacokinetics Adherence/Acceptability of Simple Antiretroviral regimens), at the COE and University Teaching Hospital in Zambia.

This trial will compare the pharmacokinetics, toxicity, acceptability, adherence, virological efficacy and cost-effectiveness of three first-line antiretroviral regimens. Both previously untreated (ARV naïve) and experienced (who have already been receiving stavudine based regimens) children ages 1 month to 13 years with undetectable viral load will be recruited. A total of 420 children (140 per site)will be recruited over a period of eighteen months and followed for a minimum of ninety six weeks

Documentary updated

A sequel to the “Living with Slim: Kids talk about HIV/AIDS” documentary originally produced in 2004 was produced recently with six of the seven children originally featured in the film. The film highlights the impact/effect antiretroviral therapy has had on their lives and shows that they can achieve their dreams.

Baseline nutritional survey

The survey aimed to establish the nutritional status of all children; and the nutritional knowledge, attitudes and practices of caretakers attending participating BIPAI Uganda sites in Kampala and Kaberamaido districts. The study showed that 12% were moderately to severely malnourished while 10% were underweight.